BLUE BELL, PA --- Wingspan Technology’s industry-leading eTMF now offers the ability for a user to browse any study in the TMF Reference Model Version 3 structure. The Reference Model browser allows a trial to be viewed in a tree structure based on the Reference Model zone, section and artifact. Any user can choose to view a study in this structure, even if it was created in an earlier version of the Reference Model or if the organization has modified the Reference Model to meet their requirements. A user can switch between this view and Wingspan’s powerful consumer-style filter navigation with a single click. The TMF Reference Model Browser provides a number of advantages over a traditional folder structure:
Clicking on any level will display a roll-up of all documents under that level. For example, clicking on the Safety Zone will show all documents across sections and artifact types within that zone. Traditional folder views would always show empty folders at the Zone and Section levels. The structure can be filtered to show specific countries and sites. As a result, it becomes much more usable than traditional folders in large studies with dozens of countries and hundreds of sites, which would otherwise result in hundreds of documents in each folder.
“Sponsors and who have committed to using the TMF Reference Model are now faced with the challenge of incorporating the best practice changes in the new Version 3,” said Kathie Clark, Wingspan’s Vice President of Product Management. “Wingspan’s TMF Reference Model browser means that they can upgrade their eTMF, even during an ongoing trial, and still see a unified presentation of a specific Trial Master File.”
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.